CN113713183A - Biomedical coating with excellent long-acting anticoagulation, antibiosis and anti-fouling performances and preparation method thereof - Google Patents
Biomedical coating with excellent long-acting anticoagulation, antibiosis and anti-fouling performances and preparation method thereof Download PDFInfo
- Publication number
- CN113713183A CN113713183A CN202111027352.2A CN202111027352A CN113713183A CN 113713183 A CN113713183 A CN 113713183A CN 202111027352 A CN202111027352 A CN 202111027352A CN 113713183 A CN113713183 A CN 113713183A
- Authority
- CN
- China
- Prior art keywords
- antibacterial
- coating
- anticoagulation
- excellent long
- biomedical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000576 coating method Methods 0.000 title claims abstract description 108
- 239000011248 coating agent Substances 0.000 title claims abstract description 105
- 230000010100 anticoagulation Effects 0.000 title claims abstract description 46
- 230000003373 anti-fouling effect Effects 0.000 title claims abstract description 45
- 238000002360 preparation method Methods 0.000 title claims abstract description 29
- 230000003115 biocidal effect Effects 0.000 title claims description 24
- 239000000178 monomer Substances 0.000 claims abstract description 47
- 230000000844 anti-bacterial effect Effects 0.000 claims abstract description 46
- 239000003242 anti bacterial agent Substances 0.000 claims abstract description 32
- 239000000463 material Substances 0.000 claims abstract description 32
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims abstract description 25
- 238000004140 cleaning Methods 0.000 claims abstract description 21
- 239000003999 initiator Substances 0.000 claims abstract description 14
- 230000007774 longterm Effects 0.000 claims abstract description 12
- 239000011259 mixed solution Substances 0.000 claims abstract description 12
- 230000002378 acidificating effect Effects 0.000 claims abstract description 9
- 238000000034 method Methods 0.000 claims abstract description 9
- 238000005286 illumination Methods 0.000 claims abstract description 4
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide Substances CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 claims description 20
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 claims description 20
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 20
- NMHMNPHRMNGLLB-UHFFFAOYSA-N phloretic acid Chemical compound OC(=O)CCC1=CC=C(O)C=C1 NMHMNPHRMNGLLB-UHFFFAOYSA-N 0.000 claims description 20
- 239000003910 polypeptide antibiotic agent Substances 0.000 claims description 20
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 claims description 16
- -1 2-(methacryloyloxy)ethyl Chemical group 0.000 claims description 10
- 229910052757 nitrogen Inorganic materials 0.000 claims description 10
- 239000012620 biological material Substances 0.000 claims description 7
- 229920000642 polymer Polymers 0.000 claims description 7
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 claims description 6
- 239000012965 benzophenone Substances 0.000 claims description 6
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 claims description 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 3
- 239000002131 composite material Substances 0.000 claims description 2
- ZJXZSIYSNXKHEA-UHFFFAOYSA-N ethyl dihydrogen phosphate Chemical compound CCOP(O)(O)=O ZJXZSIYSNXKHEA-UHFFFAOYSA-N 0.000 claims description 2
- 229910052736 halogen Inorganic materials 0.000 claims description 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 claims 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 claims 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 claims 1
- 239000000908 ammonium hydroxide Substances 0.000 claims 1
- 125000005843 halogen group Chemical group 0.000 claims 1
- 239000000017 hydrogel Substances 0.000 abstract description 42
- 210000004369 blood Anatomy 0.000 abstract description 17
- 239000008280 blood Substances 0.000 abstract description 17
- 102000004169 proteins and genes Human genes 0.000 abstract description 8
- 108090000623 proteins and genes Proteins 0.000 abstract description 8
- 238000001179 sorption measurement Methods 0.000 abstract description 8
- 239000003146 anticoagulant agent Substances 0.000 abstract description 4
- 229940127219 anticoagulant drug Drugs 0.000 abstract description 3
- 230000004913 activation Effects 0.000 abstract description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 17
- 239000008367 deionised water Substances 0.000 description 15
- 229910021641 deionized water Inorganic materials 0.000 description 15
- 239000000243 solution Substances 0.000 description 15
- 238000006243 chemical reaction Methods 0.000 description 12
- 238000011065 in-situ storage Methods 0.000 description 11
- 238000006116 polymerization reaction Methods 0.000 description 11
- 230000003213 activating effect Effects 0.000 description 9
- 238000001035 drying Methods 0.000 description 9
- 241000894006 Bacteria Species 0.000 description 8
- 229940088710 antibiotic agent Drugs 0.000 description 8
- 238000005406 washing Methods 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- BCAIDFOKQCVACE-UHFFFAOYSA-N 3-[dimethyl-[2-(2-methylprop-2-enoyloxy)ethyl]azaniumyl]propane-1-sulfonate Chemical compound CC(=C)C(=O)OCC[N+](C)(C)CCCS([O-])(=O)=O BCAIDFOKQCVACE-UHFFFAOYSA-N 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 229920002635 polyurethane Polymers 0.000 description 6
- 239000004814 polyurethane Substances 0.000 description 6
- 230000007480 spreading Effects 0.000 description 6
- 238000003892 spreading Methods 0.000 description 6
- 229920000915 polyvinyl chloride Polymers 0.000 description 5
- 239000004800 polyvinyl chloride Substances 0.000 description 5
- 108090000765 processed proteins & peptides Proteins 0.000 description 5
- 230000001954 sterilising effect Effects 0.000 description 5
- 238000004659 sterilization and disinfection Methods 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- CLSIFQGHPQDTHQ-DTWKUNHWSA-N (2s,3r)-2-[(4-carboxyphenyl)methyl]-3-hydroxybutanedioic acid Chemical compound OC(=O)[C@H](O)[C@@H](C(O)=O)CC1=CC=C(C(O)=O)C=C1 CLSIFQGHPQDTHQ-DTWKUNHWSA-N 0.000 description 4
- 229910019142 PO4 Inorganic materials 0.000 description 4
- 125000002091 cationic group Chemical group 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 239000010452 phosphate Substances 0.000 description 4
- 229920000747 poly(lactic acid) Polymers 0.000 description 4
- 239000004626 polylactic acid Substances 0.000 description 4
- 102000004196 processed proteins & peptides Human genes 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 102000044503 Antimicrobial Peptides Human genes 0.000 description 3
- 108700042778 Antimicrobial Peptides Proteins 0.000 description 3
- 208000035143 Bacterial infection Diseases 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- 208000007536 Thrombosis Diseases 0.000 description 3
- 229910001069 Ti alloy Inorganic materials 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 239000000956 alloy Substances 0.000 description 3
- 208000022362 bacterial infectious disease Diseases 0.000 description 3
- 229910010293 ceramic material Inorganic materials 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 230000035484 reaction time Effects 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 230000002785 anti-thrombosis Effects 0.000 description 2
- 239000004599 antimicrobial Substances 0.000 description 2
- 239000005313 bioactive glass Substances 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 238000005524 ceramic coating Methods 0.000 description 2
- 238000004132 cross linking Methods 0.000 description 2
- 230000003013 cytotoxicity Effects 0.000 description 2
- 231100000135 cytotoxicity Toxicity 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003527 fibrinolytic agent Substances 0.000 description 2
- 229910001385 heavy metal Inorganic materials 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 2
- 239000004810 polytetrafluoroethylene Substances 0.000 description 2
- 125000003345 AMP group Chemical group 0.000 description 1
- 239000004254 Ammonium phosphate Substances 0.000 description 1
- 208000037408 Device failure Diseases 0.000 description 1
- PQUCIEFHOVEZAU-UHFFFAOYSA-N Diammonium sulfite Chemical compound [NH4+].[NH4+].[O-]S([O-])=O PQUCIEFHOVEZAU-UHFFFAOYSA-N 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 229920000459 Nitrile rubber Polymers 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 125000003275 alpha amino acid group Chemical group 0.000 description 1
- 229910000148 ammonium phosphate Inorganic materials 0.000 description 1
- 235000019289 ammonium phosphates Nutrition 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- NTXGQCSETZTARF-UHFFFAOYSA-N buta-1,3-diene;prop-2-enenitrile Chemical compound C=CC=C.C=CC#N NTXGQCSETZTARF-UHFFFAOYSA-N 0.000 description 1
- 229920006317 cationic polymer Polymers 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 239000011247 coating layer Substances 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- MNNHAPBLZZVQHP-UHFFFAOYSA-N diammonium hydrogen phosphate Chemical compound [NH4+].[NH4+].OP([O-])([O-])=O MNNHAPBLZZVQHP-UHFFFAOYSA-N 0.000 description 1
- YSCHCBVNGBHFJV-UHFFFAOYSA-N dimethyl(3-sulfopropyl)azanium hydroxide Chemical compound [OH-].C[NH+](C)CCCS(O)(=O)=O YSCHCBVNGBHFJV-UHFFFAOYSA-N 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 229920006227 ethylene-grafted-maleic anhydride Polymers 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000002618 extracorporeal membrane oxygenation Methods 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 231100000086 high toxicity Toxicity 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 229920001477 hydrophilic polymer Polymers 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 230000015788 innate immune response Effects 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 238000005289 physical deposition Methods 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000010069 protein adhesion Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000012890 simulated body fluid Substances 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 238000006557 surface reaction Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/08—Materials for coatings
- A61L31/10—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/08—Materials for coatings
- A61L29/085—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
- A61L29/145—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
- A61L29/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/145—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/16—Biologically active materials, e.g. therapeutic substances
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
- C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
- C08F220/04—Acids; Metal salts or ammonium salts thereof
- C08F220/06—Acrylic acid; Methacrylic acid; Metal salts or ammonium salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
- A61L2300/406—Antibiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/602—Type of release, e.g. controlled, sustained, slow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/606—Coatings
- A61L2300/608—Coatings having two or more layers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Dispersion Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Materials For Medical Uses (AREA)
- Paints Or Removers (AREA)
Abstract
本发明提供了一种具有优异长效抗凝血及抗菌抗污性能的生物医用涂层及其制备方法，制备方法，依次包括以下步骤：(1)对基底材料进行清洁，然后进行引发剂的固定；(2)在光照条件下，将两性离子单体与含双键和羧基的单体反应1‑3h，清洗，得医用涂层；(3)将步骤(2)所得医用涂层置于酸性环境中，用混合液进行活化，然后加入抗菌剂反应24h，再依次经清洗和干燥，得具有优异长效抗凝血及抗菌抗污性能的生物医用涂层。本发明还包括采用上述方法制得的生物医用涂层。本发明基于含两性离子水凝胶的良好血液相容性、阻抗蛋白吸附功能和抗菌剂的杀菌作用，实现在血液接触器械表面抗凝、抗菌，抗污的目的。The present invention provides a biomedical coating with excellent long-term anticoagulation and antibacterial and antifouling properties and a preparation method thereof. The preparation method includes the following steps in sequence: (1) cleaning the base material, and then performing an initiator Fix; (2) under illumination conditions, react zwitterionic monomers with monomers containing double bonds and carboxyl groups for 1-3h, and clean to obtain medical coatings; (3) place the medical coatings obtained in step (2) on In an acidic environment, the mixed solution was used for activation, then an antibacterial agent was added to react for 24 hours, and then washed and dried in turn to obtain a biomedical coating with excellent long-term anticoagulant and antibacterial and antifouling properties. The present invention also includes the biomedical coating prepared by the above method. Based on the good blood compatibility of the zwitterion-containing hydrogel, the resistance protein adsorption function and the bactericidal effect of the antibacterial agent, the invention achieves the purposes of anticoagulation, antibacterial and antifouling on the surface of blood contacting instruments.
Description
Technical Field
The invention belongs to the technical field of biomedical materials, and particularly relates to a biomedical coating with excellent long-acting anticoagulation, antibiosis and anti-pollution performances and a preparation method thereof.
Background
Bacterial infections and thrombosis are two major complications faced by blood-contacting instruments and materials, and these problems can lead to implant failure, which in turn can cause significant pain to the patient. In clinical practice, the problem is often solved by the combination of thrombolytic drugs and antibiotics. However, overuse of thrombolytic drugs and antibiotics carries the risk of massive hemorrhage and the development of drug-resistant bacteria. Therefore, surface functionalization can be an effective means for improving the antibacterial and antithrombotic property of medical instruments and implants.
Sterilization and anti-fouling on the surface of materials are two strategies for reducing bacterial infection, the former is realized by doping heavy metal ions, coating antibiotics and coupling cationic polymers. The latter is achieved by grafting hydrophilic polymers, such as polyethylene glycol (PEG) and zwitterionic polymers. Water interacts with the hydrophilic component to form a hydrated layer. The hydrophilic component can generate steric exclusion, and nonspecific adsorption such as protein, bacteria and the like is remarkably reduced. At the same time, anti-fouling strategies are also effective against thrombi, since they have the same principle, being able to reduce the absorption and activation of platelets and fibrin. However, the anti-fouling strategy alone is not sufficient to prevent the adhesion and growth of bacteria for long periods of time. In addition, the anti-fouling surface is unable to inactivate bacteria, which can lead to infection of the blood or other parts. At the same time, the bactericidal surface also has certain disadvantages, such as short life, high toxicity, poor blood compatibility, etc., which limits its application in blood-related medical devices. From this point of view, a single functional surface with antifouling or bactericidal properties alone is not sufficient in clinical applications. At the same time, the stability of the functional surface is also a serious problem. Unstable, easily degradable surfaces do not function continuously. Therefore, a high-stability dual-functional surface with both antifouling and bactericidal properties is a feasible solution to thrombus and bacterial infection. Antimicrobial agents come in a wide variety of forms, including antibiotics, heavy metal ions, cationic substances, antimicrobial peptides, and the like. Antibiotics are an antimicrobial agent that has been used clinically in a wide range of applications, and their safety and effectiveness have been proven and tested. Antibacterial peptide is a peptide substance naturally existing in the body and is an important component of innate immunity. Antimicrobial peptides are considered to be valuable drugs that exert desirable antimicrobial properties. Many researchers have applied antibacterial peptides to surface modification, but when these peptides are immobilized as an antibacterial coating, there are many problems such as greatly reduced antibacterial activity, easy adsorption of proteins and dead bacteria, because the cationic nature of the antibacterial peptide can trigger immune response and inflammation and may block antibacterial functional groups. More importantly, due to the cationic nature of AMPs, they also readily adsorb and activate platelets, increasing the risk of thrombosis, and may also induce hemolysis of red blood cells, limiting their use in blood contacts or grafts. Among the reported antifouling surface modifications, hydrogel coating is a promising strategy. Since hydrogels have good anti-fouling properties and hemocompatibility and adjustable chemical structures. In addition, the hydrogel coating with the thickness of micron is more stable than the hydrogel coating with the thickness of nanometer, has higher strength, is firmly combined and is not easy to fall off, and the hydrogel coating can be conveniently loaded with different and abundant medicaments to complete various functions, such as antibiosis, anti-inflammation, anticoagulation and the like.
Disclosure of Invention
Aiming at the problems in the prior art, the invention provides a biomedical coating with excellent long-acting anticoagulation and antibacterial and anti-fouling performances and a preparation method thereof, and the purpose of anticoagulation, antibiosis and fouling resistance on the surface of a blood contact instrument is realized based on the good blood compatibility, the impedance protein adsorption function and the sterilization effect of an antibacterial agent of a zwitter-ion-containing hydrogel.
In order to achieve the purpose, the technical scheme adopted by the invention for solving the technical problems is as follows: the preparation method of the biomedical coating with excellent long-acting anticoagulation, antibiosis and anti-fouling performances is provided, and comprises the following steps in sequence:
(1) cleaning the substrate material, and then fixing an initiator;
(2) under the condition of illumination, reacting a zwitterionic monomer with a monomer containing double bonds and carboxyl for 1-3h, and cleaning to obtain a medical coating;
(3) and (3) placing the medical coating obtained in the step (2) in an acid environment, activating by using the mixed solution, adding an antibacterial agent to react for 24 hours, and then sequentially cleaning and drying to obtain the biomedical coating with excellent long-acting anticoagulation and antibacterial and anti-fouling performances.
The technical scheme is as follows:
(1) the substrate material is cleaned and then the initiator is fixed.
(2) In the reaction system, the concentration of the zwitterionic monomer is in the range of 2.5 wt% to 15.0 wt%, and the concentration of the monomer having a double bond and a carboxyl group is in the range of 5.0 wt% to 25.0 wt%. Under the condition of ultraviolet illumination, the two monomers undergo in-situ polymerization for 1 to 3 hours to obtain a medical coating, and after the reaction is finished, the surface is cleaned by deionized water for 2 to 3 days to remove the residual unreacted monomers. Wherein the zwitterion can be three main types of ammonium phosphate, ammonium sulfonate and ammonium carboxylate.
(3) Placing the prepared coating in an acid environment (the pH range is 5.0-6.0), activating surface carboxyl by using 1-ethyl- (3-dimethylaminopropyl) carbodiimide hydrochloride (EDC)/N-hydroxysuccinimide ester (NHS), adding an antibacterial agent into a solution system, wherein the concentration of the antibacterial agent can be 1-10mg/mL, and reacting for 24 hours. Among them, antibiotics which can be used for grafting are various, and antibiotics, antibacterial peptides having different combinations of amino acid sequences, and the like can be used.
(4) Cleaning the prepared coating for 3 times, each time for 15min, and then drying under the condition of nitrogen to obtain the coating.
Further, the substrate material is a polymer-based biomaterial or a polymer-based composite biomaterial.
Further, the polymer-based biomaterial is polyvinyl chloride, polyurethane, polylactic acid or polyvinylpyrrolidone.
Further, the initiator is a monomer containing a halogen bond, benzophenone or azobisisobutyronitrile.
Further, the zwitterion is 2- (methacryloyloxy) ethyl-2- (trimethylamino) ethyl phosphate, [2- (methacryloyloxy) ethyl ] dimethyl- (3-sulfopropyl) ammonium hydroxide, or 3- [ [2- (methacryloyloxy) ethyl ] dimethyl ammonium ] propionate.
Further, the monomer containing a double bond and a carboxyl group is methacrylic acid.
Further, the mixed solution is a mixture of 0.1 to 0.5M of 1-ethyl- (3-dimethylaminopropyl) carbodiimide hydrochloride and 0.05 to 0.2M of N-hydroxysuccinimide ester.
Further, the antibacterial agent is antibiotic or antibacterial peptide, and the concentration is 1-10 mg/mL.
Further, the concentration of the zwitterionic monomer is 2.5-15 wt%, and the concentration of the monomer containing double bonds and carboxyl groups is 5-25 wt%.
Further, in the step (3), the mixture is washed for 2 to 4 times, each time for 10 to 20min, and dried under the condition of nitrogen.
The biomedical coating with excellent long-acting anticoagulation and antibacterial anti-fouling performance prepared by the preparation method of the biomedical coating with excellent long-acting anticoagulation and antibacterial anti-fouling performance.
In summary, the invention has the following advantages:
1. the invention realizes the purposes of anticoagulation, antibiosis and stain resistance on the surface of a blood contact apparatus based on the good blood compatibility, the protein-resistant adsorption function and the sterilization function of an antibacterial agent of the hydrogel containing zwitterion. The preparation process has mild reaction conditions and simple operation. The initiator is introduced into the surface of the material in situ, and the crosslinking is initiated in situ under the irradiation of ultraviolet light to form a uniform hydrogel coating. The prepared hydrogel coating has excellent stability and can not be degraded after being soaked in simulated body fluid for one month.
2. The hydrogel coating contains zwitterions, so that a 'hydration layer' is formed on the surface of the coating by free water, and the hydrogel coating has the characteristics of anti-fouling and anticoagulation, can effectively resist nonspecific protein adhesion, and can further resist the adhesion of protein and cells in blood and the adhesion of bacteria. The introduction of the antibacterial agent enables the coating to have excellent bactericidal performance, and the type of the introduced antibacterial agent can be antibiotics, antibacterial peptides and the like. The hydrogel coating shields the cytotoxicity of the antibacterial agent, well protects the activity of the antibacterial agent and enables the coating to have a long-acting antibacterial effect.
3. The initiator can be fixed on the surface of the material in a physical deposition or immersion mode, and under the condition of ultraviolet irradiation initiation, free radicals are generated to open the double bonds of the two monomers and generate a crosslinking reaction, so that a hydrogel coating is formed on the surface of the material in situ. The unreacted monomer is then removed by prolonged washing. After cleaning, the hydrogel coating was soaked in 1-ethyl- (3-dimethylaminopropyl) carbodiimide hydrochloride (EDC)/N-hydroxysuccinimide ester (NHS) to activate surface carboxyl groups. The activated carboxyl is combined with the antibacterial agent, so that the antibacterial agent is combined on the surface of the hydrogel coating, and meanwhile, the coating is endowed with excellent bactericidal capacity. The hydrogel coating contains a large amount of zwitterions, so that the hydrogel coating has anticoagulation and anti-fouling effects. The killed bacteria can not be adhered to the surface of the coating, so that the antibacterial efficiency of the coating can not be reduced due to the accumulation of the bacteria, and in addition, the hydrogel coating protects the antibacterial agent and ensures the long-term stable antibacterial action. The zwitterion can effectively resist nonspecific protein adsorption, so that the medical coating prepared from the zwitterion can resist protein and cell adsorption in blood, and has good blood compatibility. In conclusion, the preparation method disclosed by the invention is simple to operate, the reaction conditions are mild, and the prepared coating has excellent sterilization and anti-fouling performance and blood compatibility, and provides a new idea for the antibacterial, anticoagulant and anti-fouling of a blood contact medical instrument.
4. In order to realize the dual functions of antibiosis and antithrombotic, improve the stability of the antibacterial agent and reduce the negative effect of cationic property, the invention provides an antibacterial agent-hydrogel coating embedding strategy. The embedded antibacterial agent enables the hydrogel coating to have antibacterial performance and keeps good anticoagulation and anti-fouling performance of the hydrogel coating. In this study, we chose a surface-initiated polymerization method to form a thin coating on a polymeric substrate, with acids with double bonds and zwitterions as monomers to initiate polymerization. Two different antibacterial agents are embedded into the hydrogel coating layer by adopting a physical adsorption and chemical grafting method so as to achieve the effects of anticoagulation, antibiosis and stain resistance.
5. The method is simple to operate, the reaction condition is mild, the prepared coating is firmly combined with the substrate material, and the coating simultaneously contains the zwitterionic polymer and the antibacterial agent. The zwitterion has the effects of anticoagulation and stain resistance, the hydrogel coating obtained by polymerization of the zwitterion has the protection effect on an antibacterial agent, and the cytotoxicity of the antibacterial agent is shielded, so that the material has the long-term antibacterial and stain resistance effect and also has good blood compatibility, and can be used for the anticoagulation and antibacterial application modification requirements of blood contact materials/instruments such as an extracorporeal membrane oxygenation (ECMO) circulation pipeline, a central venous catheter, a dialysis pipeline for heart failure resistance treatment, an indwelling needle and the like.
Drawings
FIG. 1 is a scanning electron microscope picture of the biomedical coating with excellent long-acting anticoagulation and antibacterial anti-fouling performance in example 1 after the biomedical coating contacts with platelets on the surface of an uncoated polytetrafluoroethylene material;
FIG. 2 is a picture of the coated plate for cloning and nutrition-enriched culture with excellent long-acting anticoagulant, antibacterial and anti-fouling performance of the biomedical coating and the surface antibacterial property of the uncoated polytetrafluoroethylene material in example 1.
Detailed Description
Example 1
A biomedical coating with excellent long-acting anticoagulation and antibacterial and anti-fouling performances is prepared by the following steps in sequence:
(1) cleaning a polyvinyl chloride conduit, and then pouring benzophenone into the polyvinyl chloride conduit for fixing;
(2) pouring a zwitterionic monomer 2- (methacryloyloxy) ethyl-2- (trimethyl amino) ethyl phosphate (MPC) and a monomer methacrylic acid (AAc) with double bonds and carboxyl into a polyvinyl chloride conduit, wherein the ratio of the two monomers is 3:7, carrying out in-situ polymerization under ultraviolet irradiation for 1 hour to obtain a hydrogel coating, and after the reaction is finished, cleaning the surface with deionized water for 2-3 days to remove residual unreacted 2- (methacryloyloxy) ethyl-2- (trimethyl amino) ethyl phosphate (MPC) and the methacrylic acid (AAc);
(3) placing the prepared hydrogel coating in an acidic environment (pH is 4.0), activating surface carboxyl by using 1-ethyl- (3-dimethylaminopropyl) carbodiimide hydrochloride (EDC)/N-hydroxysuccinimide ester (NHS), adding antibacterial peptide (with the sequence of WRWRWRWRWRWRWRWRWRWRWR-NH 2) into a solution system, and reacting for 24 hours to obtain the hydrogel-embedded antibacterial peptide coating; and (3) washing with deionized water for 15 minutes each time, and then drying under the condition of nitrogen to obtain the biomedical coating with excellent long-acting anticoagulation, antibiosis and anti-fouling performances.
Example 2
A biomedical coating with excellent long-acting anticoagulation, antibiosis and anti-pollution performance and a preparation method thereof are disclosed, the preparation method comprises the following steps:
(1) cleaning a polylactic acid material, then immersing the polylactic acid material into a benzophenone solution, and fixing an initiator;
(2) spreading mixed solution of zwitterionic monomer 2- (methacryloyloxy) ethyl-2- (trimethyl amino) ethyl phosphate (MPC) and monomer methacrylic acid (AAc) with double bonds and carboxyl on the surface of a polylactic acid material, wherein the ratio of the two monomers is 3:7, carrying out in-situ polymerization under ultraviolet irradiation for 1.5 hours to obtain a hydrogel coating, and cleaning the surface with deionized water for 2-3 days after the reaction is finished to remove residual unreacted 2- (methacryloyloxy) ethyl-2- (trimethyl amino) ethyl phosphate (MPC) and methacrylic acid (AAc);
(3) placing the prepared hydrogel coating in an acidic environment (pH is 5.5), activating surface carboxyl by using 1-ethyl- (3-dimethylaminopropyl) carbodiimide hydrochloride (EDC)/N-hydroxysuccinimide ester (NHS), adding antibacterial peptide (with the sequence of WRWRWRWRWRWRWRWRWRWRWR-NH 2) into a solution system, and reacting for 24 hours to obtain the hydrogel-embedded antibacterial peptide coating; and (3) washing with deionized water for 15 minutes each time, and then drying under the condition of nitrogen to obtain the biomedical coating with excellent long-acting anticoagulation, antibiosis and anti-fouling performances.
Example 3
A biomedical coating with excellent long-acting anticoagulation, antibiosis and anti-pollution performance and a preparation method thereof are disclosed, the preparation method comprises the following steps:
(1) cleaning a polyurethane material, then immersing the polyurethane material into an azodicarbonitrile solution, and fixing an initiator;
(2) spreading mixed solution of a zwitterionic monomer [2- (methacryloyloxy) ethyl ] dimethyl- (3-sulfopropyl) ammonium hydroxide (SBMA) and a monomer methacrylic acid (AAc) with double bonds and carboxyl on the surface of a polyurethane material, wherein the ratio of the two monomers is 2:3, carrying out in-situ polymerization under ultraviolet irradiation for 2 hours to obtain a hydrogel coating, and cleaning the surface with deionized water for 2-3 days after the reaction is finished to remove residual unreacted 2- (methacryloyloxy) ethyl ] dimethyl- (3-sulfopropyl) ammonium hydroxide (SBMA) and the methacrylic acid monomer (AAc);
(3) placing the prepared hydrogel coating in an acidic environment (pH is 5.0), activating surface carboxyl by using 1-ethyl- (3-dimethylaminopropyl) carbodiimide hydrochloride (EDC)/N-hydroxysuccinimide ester (NHS), adding antibacterial peptide (with the sequence of RLARIVVIRVAR-NH2) into a solution system, reacting for 24 hours, and thus obtaining the antibacterial peptide coating embedded in the hydrogel; and (3) washing with deionized water for 15 minutes each time, and then drying under the condition of nitrogen to obtain the biomedical coating with excellent long-acting anticoagulation, antibiosis and anti-fouling performances.
Example 4
A biomedical coating with excellent long-acting anticoagulation, antibiosis and anti-pollution performance and a preparation method thereof are disclosed, the preparation method comprises the following steps:
(1) cleaning a polyurethane material, then immersing the polyurethane material into an azodicarbonitrile solution, and fixing an initiator;
(2) spreading mixed solution of a zwitterionic monomer [2- (methacryloyloxy) ethyl ] dimethyl- (3-sulfopropyl) ammonium hydroxide (SBMA) and a monomer methacrylic acid (AAc) with double bonds and carboxyl on the surface of a stainless steel material, wherein the ratio of the two monomers is 2:3, carrying out in-situ polymerization under the irradiation of ultraviolet light, wherein the reaction time is 3 hours to obtain a hydrogel coating, and after the reaction is finished, cleaning the surface with deionized water for 2-3 days to remove residual unreacted [2- (methacryloyloxy) ethyl ] dimethyl- (3-sulfopropyl) ammonium hydroxide (SBMA) and the methacrylic acid monomer (AAc);
(3) placing the prepared hydrogel coating in an acidic environment (pH is 5.5), activating surface carboxyl by using 1-ethyl- (3-dimethylaminopropyl) carbodiimide hydrochloride (EDC)/N-hydroxysuccinimide ester (NHS), adding antibacterial peptide (with the sequence of RLARIVVIRVAR-NH2) into a solution system, reacting for 24 hours, and thus obtaining the hydrogel-embedded antibacterial peptide coating; and (3) washing with deionized water for 15 minutes each time, and then drying under the condition of nitrogen to obtain the biomedical coating with excellent long-acting anticoagulation, antibiosis and anti-fouling performances.
Example 5
A biomedical coating with excellent long-acting anticoagulation, antibiosis and anti-pollution performance and a preparation method thereof are disclosed, the preparation method comprises the following steps:
(1) cleaning a ceramic material, immersing the ceramic material in a benzophenone solution, and fixing an initiator;
(2) spreading mixed solution of a zwitterionic monomer [2- (methacryloyloxy) ethyl ] dimethyl- (3-sulfopropyl) ammonium hydroxide (SBMA) and a monomer methacrylic acid (AAc) with double bonds and carboxyl on the surface of the ceramic material, wherein the ratio of the two monomers is 1:3, carrying out in-situ polymerization under the irradiation of ultraviolet light, wherein the reaction time is 1 hour, so as to obtain a hydrogel coating, and cleaning the surface with deionized water for 2-3 days after the reaction is finished so as to remove residual unreacted [2- (methacryloyloxy) ethyl ] dimethyl- (3-sulfopropyl) ammonium hydroxide (SBMA) and the methacrylic acid monomer (AAc);
(3) placing the prepared hydrogel coating in an acidic environment (pH is 6.0), activating surface carboxyl by using 1-ethyl- (3-dimethylaminopropyl) carbodiimide hydrochloride (EDC)/N-hydroxysuccinimide ester (NHS), adding antibacterial peptide (with the sequence of WRWRWRWRWRWRWRWRWRWRWR-NH 2) into a solution system, and reacting for 24 hours to obtain the hydrogel-embedded antibacterial peptide coating; and (3) washing with deionized water for 15 minutes each time, and then drying under the condition of nitrogen to obtain the biomedical coating with excellent long-acting anticoagulation, antibiosis and anti-fouling performances.
Example 6
A biomedical coating with excellent long-acting anticoagulation, antibiosis and anti-pollution performance and a preparation method thereof are disclosed, the preparation method comprises the following steps:
(1) cleaning a medical collagen material, immersing the medical collagen material into a benzophenone solution, and fixing an initiator;
(2) spreading mixed solution of zwitterionic monomer 3- [ [2- (methacryloyloxy) ethyl ] dimethylammonium ] propionate (CBMA) and monomer methacrylic acid (AAc) with double bonds and carboxyl on the surface of the medical collagen material, wherein the ratio of the two monomers is 3:7, carrying out in-situ polymerization under the irradiation of ultraviolet light, wherein the reaction time is 1 hour, obtaining a hydrogel coating, and cleaning the surface with deionized water for 2-3 days after the reaction is finished to remove residual unreacted 3- [ [2- (methacryloyloxy) ethyl ] dimethylammonium ] propionate (CBMA) and methacrylic acid monomer (AAc);
(3) placing the prepared hydrogel coating in an acidic environment (pH is 5.5), activating surface carboxyl by using 1-ethyl- (3-dimethylaminopropyl) carbodiimide hydrochloride (EDC)/N-hydroxysuccinimide ester (NHS), adding antibacterial peptide (with the sequence of WRWRWRWRWRWRWRWRWRWRWR-NH 2) into a solution system, and reacting for 24 hours to obtain the hydrogel-embedded antibacterial peptide coating; and (3) washing with deionized water for 15 minutes each time, and then drying under the condition of nitrogen to obtain the biomedical coating with excellent long-acting anticoagulation, antibiosis and anti-fouling performances.
Example 7
A biomedical coating with excellent long-acting anticoagulation, antibiosis and anti-pollution performance and a preparation method thereof are disclosed, the preparation method comprises the following steps:
(1) cleaning the titanium alloy material reinforced by the bioactive glass ceramic coating, then immersing the titanium alloy material into an azodicarbonitrile butadiene-acrylonitrile solution, and fixing an initiator;
(2) spreading mixed solution of zwitterionic monomer 3- [ [2- (methacryloyloxy) ethyl ] dimethylammonium ] propionate (CBMA) and monomer methacrylic acid (AAc) with double bonds and carboxyl on the surface of the titanium alloy material reinforced by the bioactive glass ceramic coating, wherein the ratio of the two monomers is 2:3, carrying out in-situ polymerization under the irradiation of ultraviolet light for 1.5 hours to obtain a hydrogel coating, and cleaning the surface with deionized water for 2-3 days to remove residual unreacted 3- [ [2- (methacryloyloxy) ethyl ] dimethylammonium ] propionate (CBMA) and methacrylic acid monomer (AAc);
(3) placing the prepared hydrogel coating in an acidic environment (pH is 5.0), activating surface carboxyl by using 1-ethyl- (3-dimethylaminopropyl) carbodiimide hydrochloride (EDC)/N-hydroxysuccinimide ester (NHS), adding antibacterial peptide (with the sequence of RLARIVVIRVAR-NH2) into a solution system, reacting for 24 hours, and thus obtaining the antibacterial peptide coating embedded in the hydrogel; and (3) washing with deionized water for 15 minutes each time, and then drying under the condition of nitrogen to obtain the biomedical coating with excellent long-acting anticoagulation, antibiosis and anti-fouling performances.
The number of platelets adhered and activated on the surface of the material with hydrogel embedded antimicrobial peptide coating was significantly reduced compared to uncoated polyvinyl chloride, and the results are shown in fig. 1. In an antibacterial experiment, the antibacterial peptide coating embedded in the hydrogel also shows better antibacterial performance, the sterilization rate can reach 100%, and the result is shown in fig. 2.
The coating prepared by the method is uniform and stable in property, the raw material investment required for preparing the coating is small, the investment amount is easy to regulate and control, the coating can be modified on the surfaces of various materials without influencing the performance of the body material, the operation is simple, the cost is low, and the method is suitable for industrial production.
While the present invention has been described in detail with reference to the illustrated embodiments, it should not be construed as limited to the scope of the present patent. Various modifications and changes may be made by those skilled in the art without inventive step within the scope of the appended claims.
Claims (10)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110741200 | 2021-06-30 | ||
| CN2021107412002 | 2021-06-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN113713183A true CN113713183A (en) | 2021-11-30 |
Family
ID=78681265
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202111027352.2A Pending CN113713183A (en) | 2021-06-30 | 2021-09-02 | Biomedical coating with excellent long-acting anticoagulation, antibiosis and anti-fouling performances and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113713183A (en) |
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114432506A (en) * | 2022-03-10 | 2022-05-06 | 东莞市人民医院 | Zwitterion functionalized biological material, and preparation method and application thereof |
| CN114652900A (en) * | 2022-02-28 | 2022-06-24 | 东南大学 | A kind of hydrophilic antibacterial and anti-protein adhesion catheter, its preparation method and application |
| CN114652904A (en) * | 2022-03-17 | 2022-06-24 | 天津大学 | Anticoagulant zwitterionic hydrogel coating and preparation method thereof |
| CN115246910A (en) * | 2022-04-29 | 2022-10-28 | 上海微密医疗科技有限公司 | Synthesis method and application of polymer |
| CN115501398A (en) * | 2022-11-07 | 2022-12-23 | 四川大学 | Biocompatible anti-inflammatory hydrogel coating and preparation method thereof |
| CN115531623A (en) * | 2022-09-02 | 2022-12-30 | 金陵科技学院 | Antifouling/antibacterial nano gel coating and preparation method thereof |
| CN116003692A (en) * | 2022-05-12 | 2023-04-25 | 天津大学 | A surface-grafted and cross-linked zwitterionic polymer coating and its preparation method and application |
| CN116474175A (en) * | 2023-04-25 | 2023-07-25 | 四川大学 | A superhydrophobic coating with anticoagulant and antibacterial functions and preparation method thereof |
| CN117264486A (en) * | 2023-09-19 | 2023-12-22 | 中科融志国际科技(北京)有限公司 | Antibacterial anti-icing coating |
| CN119236188A (en) * | 2024-12-09 | 2025-01-03 | 成都德信安创新医疗技术有限公司 | An antibacterial coating based on modified parylene and preparation method thereof |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6005160A (en) * | 1996-02-22 | 1999-12-21 | National Science Council | Heterobifunctional membrane in application of artificial cornea |
| TWI609703B (en) * | 2017-04-10 | 2018-01-01 | 明基材料股份有限公司 | Ophthalmic lens and manufacturing method thereof |
| CN108129687A (en) * | 2017-12-21 | 2018-06-08 | 西安科技大学 | A kind of preparation method of surface for the imitating cell outer-layer membrane structure coating of Phosphorylcholine |
| CN108744040A (en) * | 2018-06-28 | 2018-11-06 | 西南交通大学 | Polymeric biomaterial preparation method with wear self-repair function in a kind of environment in vivo |
| CN111763284A (en) * | 2020-07-21 | 2020-10-13 | 西安科技大学 | A kind of preparation method of phosphorylcholine coating containing amino group and carboxyl group |
-
2021
- 2021-09-02 CN CN202111027352.2A patent/CN113713183A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6005160A (en) * | 1996-02-22 | 1999-12-21 | National Science Council | Heterobifunctional membrane in application of artificial cornea |
| TWI609703B (en) * | 2017-04-10 | 2018-01-01 | 明基材料股份有限公司 | Ophthalmic lens and manufacturing method thereof |
| CN108129687A (en) * | 2017-12-21 | 2018-06-08 | 西安科技大学 | A kind of preparation method of surface for the imitating cell outer-layer membrane structure coating of Phosphorylcholine |
| CN108744040A (en) * | 2018-06-28 | 2018-11-06 | 西南交通大学 | Polymeric biomaterial preparation method with wear self-repair function in a kind of environment in vivo |
| CN111763284A (en) * | 2020-07-21 | 2020-10-13 | 西安科技大学 | A kind of preparation method of phosphorylcholine coating containing amino group and carboxyl group |
Non-Patent Citations (2)
| Title |
|---|
| FANJUN ZHANG，ET AL.: "A conformally adapted all-in-one hydrogel coating: towards robust hemocompatibility and bactericidal activity", 《JOURNAL OF MATERIALS CHEMISTRY B》 * |
| YIHUA LIU，ET AL.: "Anti-platelet adhesion and in situ capture of circulating endothelial progenitor cells on ePTFE surface modified with poly(2-methacryloyloxyethyl phosphorylcholine) (PMPC) and hemocompatible peptide 1 (HCP-1)", 《COLLOIDS AND SURFACES B-BIOINTERFACES》 * |
Cited By (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114652900A (en) * | 2022-02-28 | 2022-06-24 | 东南大学 | A kind of hydrophilic antibacterial and anti-protein adhesion catheter, its preparation method and application |
| CN114432506A (en) * | 2022-03-10 | 2022-05-06 | 东莞市人民医院 | Zwitterion functionalized biological material, and preparation method and application thereof |
| CN114652904A (en) * | 2022-03-17 | 2022-06-24 | 天津大学 | Anticoagulant zwitterionic hydrogel coating and preparation method thereof |
| CN115246910A (en) * | 2022-04-29 | 2022-10-28 | 上海微密医疗科技有限公司 | Synthesis method and application of polymer |
| CN115246910B (en) * | 2022-04-29 | 2024-08-06 | 上海微密医疗科技有限公司 | Polymer synthesis method and application thereof |
| CN116003692A (en) * | 2022-05-12 | 2023-04-25 | 天津大学 | A surface-grafted and cross-linked zwitterionic polymer coating and its preparation method and application |
| WO2023216874A1 (en) * | 2022-05-12 | 2023-11-16 | 天津大学 | Surface grafted cross-linked zwitterionic polymer coating, preparation method therefor, and use thereof |
| CN116003692B (en) * | 2022-05-12 | 2024-02-09 | 天津大学 | Surface graft crosslinked zwitterionic polymer coating, and preparation method and application thereof |
| CN115531623A (en) * | 2022-09-02 | 2022-12-30 | 金陵科技学院 | Antifouling/antibacterial nano gel coating and preparation method thereof |
| CN115531623B (en) * | 2022-09-02 | 2023-08-08 | 金陵科技学院 | Antifouling/antibacterial nano gel coating and preparation method thereof |
| CN115501398B (en) * | 2022-11-07 | 2023-10-20 | 四川大学 | Biocompatible anti-inflammatory hydrogel coating and preparation method thereof |
| CN115501398A (en) * | 2022-11-07 | 2022-12-23 | 四川大学 | Biocompatible anti-inflammatory hydrogel coating and preparation method thereof |
| CN116474175A (en) * | 2023-04-25 | 2023-07-25 | 四川大学 | A superhydrophobic coating with anticoagulant and antibacterial functions and preparation method thereof |
| CN117264486A (en) * | 2023-09-19 | 2023-12-22 | 中科融志国际科技(北京)有限公司 | Antibacterial anti-icing coating |
| CN119236188A (en) * | 2024-12-09 | 2025-01-03 | 成都德信安创新医疗技术有限公司 | An antibacterial coating based on modified parylene and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN113713183A (en) | Biomedical coating with excellent long-acting anticoagulation, antibiosis and anti-fouling performances and preparation method thereof | |
| US5866113A (en) | Medical device with biomolecule-coated surface graft matrix | |
| JP2691854B2 (en) | A method for providing a bioactive surface to an article having a bioactive surface, an antithrombotic and infection resistant article, and a subcutaneously implantable article. | |
| CN112587734A (en) | Multifunctional coating based on bionic dopamine and preparation method and application thereof | |
| US5429618A (en) | Thromboresistant articles | |
| AU2009322136B2 (en) | Non-fouling, anti-microbial, anti-thrombogenic graft-from compositions | |
| CN106730051B (en) | Anticoagulation polymer biological material and preparation method and application thereof | |
| CA2732939C (en) | Immobilised biological entities | |
| JP3705740B2 (en) | Ion complex, coating body and coating method | |
| CN112717207A (en) | Long-acting antibacterial multifunctional coating based on bionic dopamine and preparation method and application thereof | |
| EP0608094A1 (en) | Biomolecule-conjugable solid surfaces | |
| WO1999016475A2 (en) | Process for preparing biologically compatible polymers and their use in medical devices | |
| AU2011225982B2 (en) | Immobilised biological entities | |
| Sun et al. | Biocompatible hierarchical zwitterionic polymer brushes with bacterial phosphatase activated antibacterial activity | |
| CN1883721A (en) | Method for modifying artificial implanter by covalent cross-linking gel | |
| CN113769177A (en) | Degradable occluder coating and preparation method thereof | |
| Sun et al. | Fast-polymerized lubricant and antibacterial hydrogel coatings for medical catheters | |
| Liu et al. | Rational design of a zwitterionic–phosphonic copolymer for the surface antifouling modification of multiple biomedical metals | |
| US8765113B2 (en) | Peptide based antimicrobial coating | |
| WO2019086618A1 (en) | Crosslinkable polypeptide and hyaluronic acid coatings | |
| CN1194778C (en) | Method for preparing heparin coating by using medical accessory equipment contacting with blood | |
| CN201510568U (en) | A heparin-coated extracorporeal circulation and cardiac assist device | |
| CN114848923B (en) | Dual-modulus multifunctional self-adaptive coating, application thereof and medical intervention catheter | |
| CN105555806A (en) | Surface modification of medical or veterinary devices | |
| JPH09103481A (en) | Medical treatment implement having surface excellent in bioadaptability and its production |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |